Back to search

Article

Left Atrial Volume Index, Other Systolic and Diastolic Transthoracic Echocardiographic Parameters as Early Predictors for Asymptomatic Trastuzumab Target Cancer Therapy-Related Cardiac Dysfunction among HER2-Positive Breast Cancer Patients at a Tertiary Medical Center in Metro Manila – a Single-Center Prospective Cohort Study

2023-07-25

Abstract excerpt

<h4>Background: </h4> A quarter of breast cancer (BrCA) patients overexpress human epidermal growth factor receptors II (HER2); associated with aggressive tumor growth and adverse prognosis. Those undergoing cancer treatment with or without radiation therapy are at higher risk for developing cancer therapy-related cardiac dysfunction (CTRCD). <h4>Methods: </h4>: This was a prospective cohort study with a computed...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7f72748b-7765-5f6f-b37b-259385411d50
DOI
10.21203/rs.3.rs-3180460/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Left Atrial Volume Index, Other Systolic and Diastolic Transthoracic Echocardiographic Parameters as Early Predictors for Asymptomatic Trastuzumab Target Cancer Therapy-Related Cardiac Dysfunction among HER2-Positive Breast Cancer Patients at a Tertiary Medical Center in Metro Manila – a Single-Center Prospective Cohort StudyDOI 10.21203/rs.3.rs-3180460/v1
Differential Genetic and Morphofunctional Patterns of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients with Pre-existing HypertensionSemantic proximity
Adjuvant Weekly Paclitaxel and Trastuzumab for HER2-Positive Breast Cancer without Risk Factors of Cardiotoxicity. Possibility of Omitting Cardiac Monitoring during Treatment.Semantic proximity
Left ventricular global longitudinal strain is worse in BRCA mutation positive breast cancer patients prior to cancer treatment and premature menopause.Semantic proximity
Prevalence and Effects of Late Cardiotoxicity induced by Anthracyclines and/or Anti- HER2 Antibodies in Patients with Breast Cancer: a real world studySemantic proximity
Cancer therapy-related cardiac dysfunction after radiation therapy for breast cancer: results from the BACCARAT cohort studySemantic proximity
How to comprehensively evaluate & manage cardiovascular risk in breast cancer survivors?Semantic proximity
Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTOSemantic proximity
The association between early‐onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple‐negative breast cancer patients and some novel autophagy‐related polymorphisms in their genomic DNA: a real‐world studySemantic proximity
Risk of heart disease following breast cancer: results from a population-based cohort studySemantic proximity
Genetic predisposition in chemotherapy-induced cardiomyopathy in a 65-year-old female with metastatic breast cancer.Semantic proximity
Cardiovascular risk of BRCA1/2 mutation carriers: A review.Semantic proximity
Toward a Better Understanding of the Differential Impact of Heart Failure Phenotypes After Breast Cancer.Semantic proximity
Select a neighboring publication to make it the new centre.